Mog & Springer works with clients to make their often complex and cutting-edge science accessible to broader audiences and key stakeholders.
Mog & Springer Communications is an independently-owned, private practice consultancy which works with pharmaceutical, biotechnology, and medical device companies in their earliest stages, helping them establish their foundational story, driving business strategy and growth. Mog and Springer’s clients are largely privately-owned, early-stage clinical companies across multiple therapeutic areas. The practice provides its clients strategy, counsel, and execution all-in-one.
Mog & Springer works in Clinical, Corporate and Investor Communications
- Long-term communications strategy development
- Earned media relations
- Crisis communications
- Board (BOD) communications
- Investor communications
- Financial announcements
- Acquisition & IPO communications
- Development announcements
- Key Opinion Leader/Investigator communications
- Congress promotional efforts
